HIGHLIGHTS
- who: Annika Mou0308ller-Kerutt and colleagues from the University Hospital of Muenster (UKM), Internal Medicine (MedD), Muenster, Germany Muenster, Muenster, Germany have published the research work: Loss of surface transport is a main cellular pathomechanism of CRB2 variants causing podocytopathies, in the Journal: (JOURNAL)
- what: The authors report the development of a robust in_vitro assay, suitable to confirm or validate given CRB2 disease-associated variants and as a screening tool to investigate the pathogenic potential of novel, so far uncharacterized CRB2 variants.
- how: For evaluation of the live-cell imaging data the authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.